), founding partner and chief executive officer of Connecticut-based Viking Global Investors, is one of the top-earning hedge fund managers. After Halvorsen started Viking Global in 1999, the hedge fund gained 22% on average annually for the next decade.
Halvorsen’s most significant transaction in the first quarter was his sale of a portion of his stake in Valeant Pharmaceuticals International Inc
), a pharmaceutical company from Montreal. Halvorsen sold 5,018,664 shares, more than 55% of his stake, for an average price of $177.4 per share. The deal had a -3.32% impact on Halvorsen’s portfolio. Continue Reading »